TY - JOUR AU - Lee, I-Yun AU - Lin, Yin-Yin AU - Yang, Yao-Hsu AU - Lin, Yu-Shin AU - Lin, Chun-Liang AU - Lin, Wei-Yu AU - Cheng, Yu-Ching AU - Shu, Li-Hsin AU - Wu, Ching-Yuan PY - 2018 DA - 2018/01/31 TI - Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway JO - BMC Pharmacology and Toxicology SP - 5 VL - 19 IS - 1 AB - Radiotherapy plays an important role in the treatment of prostate cancer. Despite that sophisticated techniques of radiotherapy and radiation combined with chemotherapy were applied to the patients, some tumors may recur. Therefore, the study investigated the effect of dihydroisotanshinone I (DT) and the combination treatment of 5 μM DT and 5Gy irradiation (IR) against the migration ability of prostate cancer cells. SN - 2050-6511 UR - https://doi.org/10.1186/s40360-018-0195-4 DO - 10.1186/s40360-018-0195-4 ID - Lee2018 ER -